MineBio Life Sciences Limited is a life sciences. Over the past three years, MineBio Life Sciences Limited has been involved in 1 licensing and acquisition transaction, with a primary focus on Cell Therapy (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Cell Therapy
Focus Area
Other
Licensing, acquisition, and partnership transactions involving MineBio Life Sciences Limited in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| CliniControl™ cGMP media platforms and research-grade bioprocessing media | RoosterBio, Inc. | Cell Therapy | Approved | license | Apr 2026 |
Therapeutic areas and modalities where MineBio Life Sciences Limited is most active based on deal history and clinical trial data.
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Other assets — powered by data from 3,500+ real biopharma transactions.
Cell Therapy Benchmarks
Upfront, milestone, and royalty benchmarks for cell therapy deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
MineBio Life Sciences Limited is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, MineBio Life Sciences Limited ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for MineBio Life Sciences Limited include Other (2 deals and trials). In terms of modality, MineBio Life Sciences Limited has shown particular interest in cell therapy.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for MineBio Life Sciences Limited and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against MineBio Life Sciences Limited's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.
© 2026 Ambrosia Ventures. All rights reserved.
Benchmarks powered by 3,000+ real biopharma licensing deals